Real-World data shows how long patients stay on secukinumab for skin and joint conditions
NCT ID NCT05155098
First seen Dec 29, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study followed 127 adults with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis for 2 years to see how long they stayed on secukinumab treatment and how their quality of life changed. Researchers collected real-life data from medical records and patient questionnaires. The goal was to understand treatment patterns and effectiveness outside of a controlled clinical trial setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Songkhla, Hat Yai, 90110, Thailand
-
Novartis Investigative Site
Muang, Thailand, 12120, Thailand
-
Novartis Investigative Site
Khon Kaen, THA, 40002, Thailand
-
Novartis Investigative Site
Bangkok, 10300, Thailand
-
Novartis Investigative Site
Bangkok, 10330, Thailand
-
Novartis Investigative Site
Bangkok, 10400, Thailand
-
Novartis Investigative Site
Bangkok, 10700, Thailand
-
Novartis Investigative Site
Chiang Mai, 50200, Thailand
-
Novartis Investigative Site
Kaen, 40000, Thailand
-
Novartis Investigative Site
Nakhon Ratchasima, 30000, Thailand
Conditions
Explore the condition pages connected to this study.